Eli Lilly to acquire Seattle-area biotech in $1.5 billion bet on next-generation shingles vaccine
- Posted on May 27, 2026
- By Bing News
- 0 Views
- 1 min read
Eli Lilly to acquire Seattle-area biotech in $1.5 billion bet on next-generation shingles vaccine
Eli Lilly agreed to acquire Bothell, Wash.-based Curevo Vaccine for up to $1.5 billion in cash.
